621PDA Phase 2b of eryaspase in combination with gemcitabine or FOLFOX as second-line therapy in patients with metastatic pancreatic adenocarcinoma (NCT02195180) - Hammel, P; Bachet, J B; Portales, F (2017)
mdx369.005-mdx369.005